Allelic Differences in a Quantitative Trait Locus Affecting Insulin-like Growth Factor-I Impact Skeletal Acquisition and Body Composition

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2004 Nov 19

PMID 15549416

Citations 10

Authors

Clifford J Rosen

Cheryl Ackert-Bicknell

Wesley G Beamer

Tracy Nelson

Martin Adamo

Pinchas Cohen

Mary L Bouxsein

Mark C Horowitz

Affiliations

Soon will be listed here.

Abstract

Insulin-like growth factor-I (IGF-I) is critical for optimal skeletal growth and maintenance. Knockout and transgenic models have provided significant insights into the role of IGF-I in bone modeling and remodeling. Congenic mice demonstrate allelic differences in particular quantitative trait loci (QTL). One such model is congenic 6T, which contains a QTL for reduced serum IGF-I donated from C3H/HeJ on a pure C57Bl/6 J (B6) background. In this study we found a 30%-50% reduction in IGF-I expression in bone, liver, and fat of the congenic 6T mouse, as well as lower circulating IGF-I compared with control B6. 6T mice also had a greater percentage body fat, but reduced serum leptin. These changes were associated with reduced cortical and trabecular bone mineral density, impaired bone formation but no change in bone resorption. Moreover, the anabolic skeletal response to intermittent parathyroid hormone (PTH) therapy was blunted in 6T compared with B6, potentially in response to greater programmed cell death in osteocytes and osteoblasts of 6T. In summary, allelic differences in IGF-I expression impact peak bone acquisition and body composition, as well as the skeletal response to PTH. Lifelong changes in circulating and skeletal IGF-I may be relevant for the pathophysiology of several diseases, including chronic renal failure.

Citing Articles

Anabolic actions of PTH in murine models: two decades of insights.

Zweifler L, Koh A, Daignault-Newton S, McCauley L J Bone Miner Res. 2021; 36(10):1979-1998.

PMID: 34101904 PMC: 8596798. DOI: 10.1002/jbmr.4389.

Mapping the epistatic network underlying murine reproductive fatpad variation.

Jarvis J, Cheverud J Genetics. 2010; 187(2):597-610.

PMID: 21115969 PMC: 3030499. DOI: 10.1534/genetics.110.123505.

Nocturnin: a circadian target of Pparg-induced adipogenesis.

Kawai M, Green C, Horowitz M, Ackert-Bicknell C, Lecka-Czernik B, Rosen C Ann N Y Acad Sci. 2010; 1192:131-8.

PMID: 20392228 PMC: 3503505. DOI: 10.1111/j.1749-6632.2009.05221.x.

Percent fat mass is inversely associated with bone mass and hip geometry in rural Chinese adolescents.

Hong X, Arguelles L, Liu X, Tsai H, Hsu Y, Wang B J Bone Miner Res. 2010; 25(7):1544-54.

PMID: 20200956 PMC: 3153997. DOI: 10.1002/jbmr.40.

Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I.

Ackert-Bicknell C, Shockley K, Horton L, Lecka-Czernik B, Churchill G, Rosen C Endocrinology. 2008; 150(3):1330-40.

PMID: 18948404 PMC: 2654751. DOI: 10.1210/en.2008-0936.

References

Jia D, Heersche J . Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone. Bone. 2000; 27(6):785-94. DOI: 10.1016/s8756-3282(00)00400-2. View

Iida-Klein A, Lu S, Yokoyama K, Dempster D, Nieves J, Lindsay R . Precision, accuracy, and reproducibility of dual X-ray absorptiometry measurements in mice in vivo. J Clin Densitom. 2003; 6(1):25-33. DOI: 10.1385/jcd:6:1:25. View

Yakar S, Rosen C, Beamer W, Ackert-Bicknell C, Wu Y, Liu J . Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002; 110(6):771-81. PMC: 151128. DOI: 10.1172/JCI15463. View

Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker K . Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002; 111(3):305-17. DOI: 10.1016/s0092-8674(02)01049-8. View

Yakar S, Rosen C . From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Exp Biol Med (Maywood). 2003; 228(3):245-52. DOI: 10.1177/153537020322800302. View

Rosen C, Dimai H, Vereault D, Donahue L, Beamer W, Farley J . Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone. 1997; 21(3):217-23. DOI: 10.1016/s8756-3282(97)00143-9. View

Hayden J, Mohan S, Baylink D . The insulin-like growth factor system and the coupling of formation to resorption. Bone. 1995; 17(2 Suppl):93S-98S. DOI: 10.1016/8756-3282(95)00186-h. View

Middleton J, Arnott N, Walsh S, Beresford J . Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone. 1995; 16(3):287-93. DOI: 10.1016/8756-3282(94)00040-9. View

Bouxsein M, Rosen C, Turner C, Ackert C, Shultz K, Donahue L . Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo. J Bone Miner Res. 2002; 17(4):570-9. DOI: 10.1359/jbmr.2002.17.4.570. View

10.

Zhang M, Xuan S, Bouxsein M, von Stechow D, Akeno N, Faugere M . Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002; 277(46):44005-12. DOI: 10.1074/jbc.M208265200. View

11.

Jilka R, Weinstein R, Bellido T, Roberson P, Parfitt A, Manolagas S . Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999; 104(4):439-46. PMC: 408524. DOI: 10.1172/JCI6610. View

12.

Bikle D, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen C . Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res. 2002; 17(9):1570-8. DOI: 10.1359/jbmr.2002.17.9.1570. View

13.

Rosen C, Churchill G, Donahue L, Shultz K, Burgess J, Powell D . Mapping quantitative trait loci for serum insulin-like growth factor-1 levels in mice. Bone. 2000; 27(4):521-8. DOI: 10.1016/s8756-3282(00)00354-9. View

14.

Bell G, Stempien M, Fong N, Rall L . Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors. Nucleic Acids Res. 1986; 14(20):7873-82. PMC: 311821. DOI: 10.1093/nar/14.20.7873. View

15.

McCarthy T, Centrella M, Canalis E . Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology. 1989; 124(3):1247-53. DOI: 10.1210/endo-124-3-1247. View

16.

Schmittgen T, Zakrajsek B . Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods. 2000; 46(1-2):69-81. DOI: 10.1016/s0165-022x(00)00129-9. View

17.

Turner C, Sun Q, Schriefer J, Pitner N, Price R, Bouxsein M . Congenic mice reveal sex-specific genetic regulation of femoral structure and strength. Calcif Tissue Int. 2003; 73(3):297-303. DOI: 10.1007/s00223-002-1062-1. View